These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30548122)

  • 1. Orange is the new black: Kinases are the new master regulators of tumor suppression.
    An E; Brognard J
    IUBMB Life; 2019 Jun; 71(6):738-748. PubMed ID: 30548122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
    Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
    Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.
    Ahn YH; Yang Y; Gibbons DL; Creighton CJ; Yang F; Wistuba II; Lin W; Thilaganathan N; Alvarez CA; Roybal J; Goldsmith EJ; Tournier C; Kurie JM
    Mol Cell Biol; 2011 Nov; 31(21):4270-85. PubMed ID: 21896780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mitogen-activated protein kinase kinase 4 in cancer.
    Whitmarsh AJ; Davis RJ
    Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Kake S; Usui T; Ohama T; Yamawaki H; Sato K
    Oncol Rep; 2017 Feb; 37(2):1100-1106. PubMed ID: 28075459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical changes of ATP binding pocket may explain loss of kinase activity in mutant DAPK3 in cancer: A molecular dynamic simulation analysis.
    Agarwal T; Annamalai N; Maiti TK; Arsad H
    Gene; 2016 Apr; 580(1):17-25. PubMed ID: 26748242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
    Isakov N
    Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C as a tumor suppressor.
    Newton AC
    Semin Cancer Biol; 2018 Feb; 48():18-26. PubMed ID: 28476658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase.
    Brognard J; Zhang YW; Puto LA; Hunter T
    Cancer Res; 2011 Apr; 71(8):3152-61. PubMed ID: 21487036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.
    Das TP; Suman S; Papu John AM; Pal D; Edwards A; Alatassi H; Ankem MK; Damodaran C
    Cancer Lett; 2016 Jul; 377(2):134-9. PubMed ID: 27126362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.
    Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
    Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RACK1 mediates activation of JNK by protein kinase C [corrected].
    López-Bergami P; Habelhah H; Bhoumik A; Zhang W; Wang LH; Ronai Z
    Mol Cell; 2005 Aug; 19(3):309-20. PubMed ID: 16061178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
    Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
    Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Otto KB; Acharya SS; Robinson VL
    Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis.
    Xu Z; Maroney AC; Dobrzanski P; Kukekov NV; Greene LA
    Mol Cell Biol; 2001 Jul; 21(14):4713-24. PubMed ID: 11416147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7.
    Kawakami Y; Hartman SE; Holland PM; Cooper JA; Kawakami T
    J Immunol; 1998 Aug; 161(4):1795-802. PubMed ID: 9712046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.